Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia

Haematologica. 2014 Oct;99(10):e185-7. doi: 10.3324/haematol.2014.109827. Epub 2014 Jun 27.
No abstract available

Keywords: AML; CBF; daunorubicin intensification.

Publication types

  • Letter

MeSH terms

  • Anthracyclines / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Core Binding Factors / genetics
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / mortality
  • Remission Induction
  • Treatment Outcome

Substances

  • Anthracyclines
  • Antineoplastic Agents
  • Core Binding Factors